White House Urges Congress to Codify MFN Drug Pricing as Part of 'Great Healthcare Plan' - 340B Report

White House Urges Congress to Codify MFN Drug Pricing as Part of 'Great Healthcare Plan' - 340B Report

President Donald Trump has called on federal lawmakers to pass a major health care bill that includes language to codify his administration’s efforts to align U.S. drug prices with those paid by other wealthy nations—also known as “most favored nation” (MFN) pricing.

How MFN Pricing in Part B May Affect Beneficiary OOP Costs

Background In 2025, the Trump administration advanced a series of regulatory and policy actions aimed at aligning US drug prices with those paid in economically comparable countries through Most-Favored Nation (MFN) pricing. In May, President Trump signed an Executive Order directing federal agencies to pursue policies advancing MFN pricing and to explore both mandatory and voluntary implementation pathways across federal healthcare programs. On…